Navigation Links
Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
Date:11/12/2013

SAN DIEGO, Nov. 12, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced business and financial results for the third quarter ended September 30, 2013.

For the three months ended September 30, 2013, Orexigen reported a net loss of $18.6 million, or $0.19 per share, as compared to a net loss of $30.6 million, or $0.44 per share, for the third quarter of 2012.

Total operating expenses for the third quarter of 2013 were $19.4 million compared to $31.5 million for the third quarter of 2012. This overall decrease in operating expenses reflects a decrease in research and development expenses associated with the conduct of the Light Study, the Contrave® cardiovascular outcomes trial. As of September 30, 2013, Orexigen had $48.7 million in cash and cash equivalents and an additional $34.1 million in marketable securities, for a total of $82.8 million.

Orexigen indicated that 2013 change in cash, cash equivalents, and marketable securities is trending to the lower end of the guidance range.  Orexigen now projects 2013 net decrease in cash, cash equivalents, and marketable securities to be between $70 million and $75 million.  The Company will commence certain active pharmaceutical ingredient (API) purchases after the Light Study interim analysis, in order to fulfill Contrave launch order requirements, which will be subsequently reimbursed by its North American commercial partner, Takeda Pharmaceuticals, once final product is shipped.  With this updated guidance, Orexigen expects to end the year with approximately $62-$67 million in cash, cash equivalents, and marketable securities.

"This is an exciting time at Orexigen, as we make final preparations for the Light Study interim analysis," said Michael Narachi, Chief Executive Officer of Orex
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
2. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
3. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
4. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
5. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
7. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
8. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
9. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
10. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
11. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... MILFORD, Conn. , June 3, 2015 /PRNewswire/ ... of innovative access technologies for minimally invasive surgery ... the AirSeal® System in over 250,000 procedures.  Adoption ... global procedures over last year, driven by the ... market as well as geographic expansion to over ...
(Date:6/3/2015)... aTyr Pharma, Inc. (NASDAQ: LIFE ), a ... therapeutics to address rare diseases, today announced the Company,s participation ... Conference to be held at the Four Seasons Hotel in ... John Mendlein , aTyr,s CEO and Executive Chairman, ... 9:20 a.m. CT on Wednesday, June 10, 2015. The presentation ...
(Date:6/3/2015)... GAITHERSBURG, Md. , June 3, 2015  GenVec, ... collaboration with Dr. David T. Curiel and ... University at St. Louis (WUSTL).  ... Center and the Cancer Biology Division within the Department ... GenVec and the WUSTL team will create modified versions ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4
... DAYTON, Ohio , Jan. 18 ...  active and passive containers for transporting temperature sensitive pharmaceutical ... a provider of active container solutions for the temperature ... controlled containers for use in shipping and storing blood, ...
... Mich., Jan. 7 Perrigo Company (Nasdaq: PRGO ; ... Papa will present at the 28th Annual J.P. Morgan Healthcare ... the Westin St. Francis Hotel in San Francisco. , ... manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, ...
Cached Medicine Technology:AcuTemp Thermal Systems and CSafe, LLC to Offer Temperature Controlled Containers to Aid in Relief Efforts in Haiti 2AcuTemp Thermal Systems and CSafe, LLC to Offer Temperature Controlled Containers to Aid in Relief Efforts in Haiti 3
(Date:6/3/2015)... “ Harmony ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... improve some aspect of their life. , A common mistake ... with difficulties in their life. However, hypnotherapy is intended for ...
(Date:6/3/2015)... June 03, 2015 On June 22, 2015, ... of genetic drug sensitivity (pharmacogenetic) testing that it has reimbursed ... as many as 19 million of the 49 million Medicare ... costly and life-threatening adverse drug events.(1) Sadly, if it became ... , Precision Medicine, the use of an individual’s genetic information ...
(Date:6/3/2015)... York, NY (PRWEB) June 03, 2015 Dr. ... New York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in ... appointments on weekdays to his practice. In most cases, depending ... time of the day they call, they will be seen ... “My first priority as a cardiologist is to ensure that ...
(Date:6/3/2015)... DC (PRWEB) June 03, 2015 Alberto ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Global Connector Award that annually recognizes one DIA ... has advanced the mission of DIA to foster innovation ...
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will be ... Annual Meeting. DIA’s Global Inspire Award program recognizes the ... and commitment to service on a global scale. ... Award that recognizes the “Member of the Year” who ... who has contributed to the advancement of DIA’s mission. ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3
... groundbreaking Healthy Kids Program offers tools for family ... estimated at $14 billion annually- Employers and health ... of its kind personalized solution that provides tools ... and helps parents and kids become healthierMARIETTA, Ga., ...
... get on the map. , ... Washington, DC -- ... fundraiser challenge today to raise money to send lifesaving bed nets ... killer of refugees. Supporters are holding hundreds of fundraisers across the ...
... to Deliver eBill and Attachment Support for ... PECOS, N.M. and CONCORD, Calif., April 1 ... processing company serving the medical community, and ... integrated eBill and payment compliance services to ...
... to demonstrate HL7 interoperability for the Department of Defense,s MiCare System at ... ... 2009 -- iNTERFACEWARE is pleased to announce that its Iguana ... IHE demonstration of MiCare at the HIMSS Convention in Chicago next week. ...
... Más Pequeño del Mundo se ha introducido por MiCigarrillo™. El ... millones de fumadores en todo el mundo. , ... ... fumadores son adictos a la nicotina que se encuentra en ...
... talk about it with your doctor, but if childbirth ... pelvic organs, you need to know help is possible. ... Southeast Urogynecology at Women,s Specialty Center in Jackson, Miss. ... the entire southeast performing minimally invasive laparoscopic surgery at ...
Cached Medicine News:Health News:New Online Program Helps Parents Tackle Childhood Obesity 2Health News:New Online Program Helps Parents Tackle Childhood Obesity 3Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 2Health News:Nothing But Nets Launches World Malaria Day Fundraising Challenge 3Health News:CLAIM.MD Adds Jopari Workers' Compensation Connectivity 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 2Health News:Iguana Selected for Department of Defense IHE Demonstration at HIMSS 09 3Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 2Health News:Cigarrillo Electronico "Excelente 2009" Introducido por MiCigarrillo™ 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 2Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 3Health News:New Procedure To Correct Pelvic Prolapse Has Faster Recovery, Shorter Hospital Stay 4
... 3D Signature is a state of ... that integrates blood, sterile body fluid ... powerful microbiology workstation with comprehensive capabilities. ... identification and where expanded flexibility in ...
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid ANA II System, a microbial identification system....
IDS Rapid SS/u, a microbial identification system....
Medicine Products: